Kiniksa Pharmaceuticals International, plc (KNSA) Gross margin 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) gross margin by fiscal year — reported gross profit divided by reported revenue.
88.5%FY2025 · since FY2021: 76.4% → 88.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 88.5% | +2.9 pp |
| FY2024 | 85.6% | -2.0 pp |
| FY2023 | 87.6% | -2.0 pp |
| FY2022 | 89.6% | +13.2 pp |
| FY2021 | 76.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice